Delivery Order SPE2DB20D1109-SPE2DB25FP04Y
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,602.89, is for the delivery of 4,561,059,478 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,730.72 firm-fixed-price contract is for the delivery of 4,568,076 units of the medication Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a $2,124.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg ondansetron hydrochloride tablets. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a primary vehicle for providing...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,977.03 firm fixed-price contract is for the delivery of 4,567,875,611 units of the prescription medication Ondansetron HCL 4 mg tablet. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a $23,835.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 units of the medication Ondansetron HCL 4 mg Tablet. The contract has an ultimate completion date of May 19, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,158.00, is for the delivery of 4,568,013,655 units of Ondansetron HCL 4 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through April 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,715.35 fixed-price contract is for the delivery of 4,563,432,604 units of ondansetron ODT 4 mg tablets. The IDC has a potential value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.81 firm fixed-price contract is for the delivery of Ondansetron HCL 4 mg tablets. The contract is not set-aside and has an ultimate completion date of May 19, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,377.96, is for the delivery of 4,567,553,701 units of Ondansetron ODT 4 mg tablets. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,751.14, is for the delivery of ondansetron ODT 4 mg tablets. This is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...